MX2017012387A - Derivados fusionados triciclicos de 1-(ciclo)alquil piridin-2-ona utiles para el tratamiento de cancer. - Google Patents
Derivados fusionados triciclicos de 1-(ciclo)alquil piridin-2-ona utiles para el tratamiento de cancer.Info
- Publication number
- MX2017012387A MX2017012387A MX2017012387A MX2017012387A MX2017012387A MX 2017012387 A MX2017012387 A MX 2017012387A MX 2017012387 A MX2017012387 A MX 2017012387A MX 2017012387 A MX2017012387 A MX 2017012387A MX 2017012387 A MX2017012387 A MX 2017012387A
- Authority
- MX
- Mexico
- Prior art keywords
- useful
- treatment
- present description
- cyclo
- cancer
- Prior art date
Links
- -1 alkyl pyridin-2-one Chemical compound 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente descripción describió compuestos heterocíclicos de la Fórmula I o, sus estereoisómeros, sales farmacéuticamente aceptables, complejos, hidratos, solvatos, tautómeros, polimorfos, mezclas racémicas, formas ópticamente activas y derivado farmacéuticamente activo de los mismos y composiciones farmacéuticas que los contienen como el ingrediente activo; la presente descripción también describe la síntesis y caracterización de compuestos mencionados anteriormente para exhibir alta actividad anticancerígena; los compuestos de la presente descripción son útiles como medicamentos y su uso en la elaboración de medicamentos para tratamiento, prevención o supresión de enfermedades, y condiciones mediadas por una o más familias BET de bromodominios. (ver Fórmula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1636CH2015 | 2015-03-30 | ||
| PCT/IN2016/050098 WO2016157221A1 (en) | 2015-03-30 | 2016-03-30 | Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017012387A true MX2017012387A (es) | 2018-06-11 |
| MX376112B MX376112B (es) | 2025-03-07 |
Family
ID=56015058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017012387A MX376112B (es) | 2015-03-30 | 2016-03-30 | Derivados fusionados tricíclicos de 1-(ciclo)alquil piridin-2-ona como compuestos inhibidores de la familia bet de bromodominios, y el uso de los mismos en el tratamiento de trastornos proliferativos o cáncer. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10689390B2 (es) |
| EP (1) | EP3277683B1 (es) |
| JP (1) | JP6764877B2 (es) |
| KR (1) | KR102588109B1 (es) |
| CN (1) | CN107548393B (es) |
| AU (1) | AU2016242473B2 (es) |
| BR (1) | BR112017020739B1 (es) |
| CA (1) | CA2980266C (es) |
| DK (1) | DK3277683T3 (es) |
| ES (1) | ES2911886T3 (es) |
| IL (1) | IL254528B (es) |
| MX (1) | MX376112B (es) |
| PL (1) | PL3277683T3 (es) |
| PT (1) | PT3277683T (es) |
| RU (1) | RU2721120C2 (es) |
| WO (1) | WO2016157221A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20210581T1 (hr) * | 2015-09-09 | 2021-05-28 | Jubilant Biosys Limited | Triciklički kondenzirani derivati piridin-2-ona i njihova upotreba kao inhibitora brd4 |
| KR20190075131A (ko) * | 2016-11-10 | 2019-06-28 | 뤄신 파마슈티컬 (상하이) 컴퍼니 리미티드 | 질소 함유 거대 고리계 화합물, 이의 제조 방법, 약물 조성물 및 용도 |
| WO2019214399A1 (zh) * | 2018-05-10 | 2019-11-14 | 罗欣药业(上海)有限公司 | 苯并七元杂环类化合物、其制备方法、药物组合物及应用 |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| US12527741B2 (en) | 2021-06-17 | 2026-01-20 | Wisconsin Alumni Research Foundation | Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545767A (en) * | 1976-06-30 | 1979-05-16 | Aspro Nicholas Ltd | Isoquinoline derivatives |
| JPWO2008133288A1 (ja) | 2007-04-25 | 2010-07-29 | 第一三共株式会社 | 三環性アリール化合物 |
| EP2276767B1 (en) * | 2008-03-31 | 2014-05-07 | Genentech, Inc. | Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| ES2526671T3 (es) * | 2010-06-22 | 2015-01-14 | Glaxosmithkline Llc | Compuestos de benzotriazoldiazepina inhibidores de bromodominios |
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| MA38346B1 (fr) * | 2013-02-19 | 2019-05-31 | Bayer Pharma AG | 2,3-benzodiazépines bicyclo- et spirocyclosubstituées |
| EP2970330B1 (en) * | 2013-03-12 | 2019-04-17 | AbbVie Inc. | Tetracyclic bromodomain inhibitors |
| WO2015018520A1 (en) | 2013-08-06 | 2015-02-12 | Oncoethix Sa | A bet-brd inhibitor represents a novel agent for alk positive anaplastic large cell lymphoma |
| US9814728B2 (en) | 2013-09-20 | 2017-11-14 | Saint Louis University | Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi) |
-
2016
- 2016-03-30 CA CA2980266A patent/CA2980266C/en active Active
- 2016-03-30 US US15/562,381 patent/US10689390B2/en active Active
- 2016-03-30 KR KR1020177031273A patent/KR102588109B1/ko active Active
- 2016-03-30 DK DK16723536.5T patent/DK3277683T3/da active
- 2016-03-30 WO PCT/IN2016/050098 patent/WO2016157221A1/en not_active Ceased
- 2016-03-30 PT PT167235365T patent/PT3277683T/pt unknown
- 2016-03-30 RU RU2017135205A patent/RU2721120C2/ru active
- 2016-03-30 CN CN201680020269.3A patent/CN107548393B/zh active Active
- 2016-03-30 MX MX2017012387A patent/MX376112B/es active IP Right Grant
- 2016-03-30 ES ES16723536T patent/ES2911886T3/es active Active
- 2016-03-30 AU AU2016242473A patent/AU2016242473B2/en active Active
- 2016-03-30 PL PL16723536T patent/PL3277683T3/pl unknown
- 2016-03-30 BR BR112017020739-7A patent/BR112017020739B1/pt active IP Right Grant
- 2016-03-30 EP EP16723536.5A patent/EP3277683B1/en active Active
- 2016-03-30 JP JP2017551712A patent/JP6764877B2/ja active Active
-
2017
- 2017-09-17 IL IL254528A patent/IL254528B/en active IP Right Grant
-
2020
- 2020-05-07 US US16/869,517 patent/US11319326B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200331926A1 (en) | 2020-10-22 |
| KR102588109B1 (ko) | 2023-10-12 |
| RU2017135205A3 (es) | 2019-07-17 |
| US10689390B2 (en) | 2020-06-23 |
| DK3277683T3 (en) | 2022-05-02 |
| RU2017135205A (ru) | 2019-04-10 |
| KR20170132278A (ko) | 2017-12-01 |
| PT3277683T (pt) | 2022-06-28 |
| WO2016157221A1 (en) | 2016-10-06 |
| BR112017020739A2 (pt) | 2018-07-17 |
| CN107548393A (zh) | 2018-01-05 |
| AU2016242473B2 (en) | 2020-06-25 |
| US20180282345A1 (en) | 2018-10-04 |
| RU2721120C2 (ru) | 2020-05-15 |
| CA2980266A1 (en) | 2016-10-06 |
| CN107548393B (zh) | 2021-03-02 |
| EP3277683A1 (en) | 2018-02-07 |
| JP6764877B2 (ja) | 2020-10-07 |
| IL254528A0 (en) | 2017-11-30 |
| HK1248686A1 (zh) | 2018-10-19 |
| CA2980266C (en) | 2025-05-06 |
| ES2911886T3 (es) | 2022-05-23 |
| IL254528B (en) | 2020-11-30 |
| MX376112B (es) | 2025-03-07 |
| JP2018510203A (ja) | 2018-04-12 |
| AU2016242473A1 (en) | 2017-10-26 |
| EP3277683B1 (en) | 2022-03-09 |
| BR112017020739B1 (pt) | 2023-03-14 |
| NZ735972A (en) | 2024-08-30 |
| US11319326B2 (en) | 2022-05-03 |
| PL3277683T3 (pl) | 2022-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022001357A2 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
| CL2019001077A1 (es) | Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer. | |
| CO2017002998A2 (es) | Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1 | |
| MX2018002738A (es) | Derivados de piridin-2-ona fusionados triciclicos, y su uso como inhibidores de brd4. | |
| MX2019010354A (es) | Derivado de heteroaril[4,3-c]pirimidina-5-amina, metodo de preparacion del mismo y usos medicos del mismo. | |
| CU20160109A7 (es) | Compuestos de indazol como inhibidores de irak4 | |
| CO2018001268A2 (es) | Derivados de heteroarilo como inhibidores de parp | |
| MX2018003432A (es) | Compuestos heterociclicos y usos de los mismos. | |
| MX2017016344A (es) | Compuestos de benzoxacepina oxazolidinona y metodos de uso. | |
| UY40230A (es) | Macrociclos con grupos P2’ heterocíclicos como inhibidores del factor XIa y composiciones farmacéuticas que los comprenden | |
| UY36244A (es) | Derivados de la pirimidinona como inhibidores del factor xia y/o de la calicreína plasmática y composiciones farmacéuticas que los contienen | |
| BR112016016844A2 (pt) | Compostos heterocíclicos | |
| ECSP17007208A (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
| CR20140399A (es) | Pirrolidina-2-carboxamidas sustituidas | |
| MX2018005725A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer. | |
| MX2018003993A (es) | Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica. | |
| CO2017009353A2 (es) | Derivados de heteroarilos bicíclicos fusionados con actividad como inhibidores de phd | |
| SA519402103B1 (ar) | 1,6-naphthyridine مشتقات 1، 6 نفثيرايدين CDK4/6 على شكل مثبط | |
| CO7280475A2 (es) | Derivados de azaindol que actuan como inhibidores de pi3k | |
| MX2017012387A (es) | Derivados fusionados triciclicos de 1-(ciclo)alquil piridin-2-ona utiles para el tratamiento de cancer. | |
| UY35419A (es) | Inhibidores de cdk9 quinasa de pirrolo (2,3- b) piridina | |
| UY36124A (es) | Derivados de carboxamida | |
| CO2017005806A2 (es) | Nuevos derivados de bencimidazol como agentes antihistamínicos | |
| AR099867A1 (es) | Compuestos imidazobenzotiazolo fusionados | |
| UY38006A (es) | Inhibidores de la quinasa mtor, composiciones farmacéuticas que los contienen, y al uso en terapia de tales compuestos y composiciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |